Christos C. Zouboulis

机构：Städtisches Klinikum Dessau, Deutsche Telekom (Germany), Medizinische Hochschule Brandenburg Theodor Fontane, Hidradenitis Suppurativa Foundation, The University of Tokyo · ORCID：0000-0003-1646-2608

发表论文 2154 篇 · 总被引 46148 次 · h-index 110

代表论文

• Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics (2025 · Journal of the European Academy of Dermatology and Venereology · 被引 7)
• Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension (2025 · Journal of the American Academy of Dermatology · 被引 6)
• A Comprehensive Review: The Bidirectional Role of Sebum in Skin Health (2025 · Bioengineering · 被引 4)
• Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial (2025 · British Journal of Dermatology · 被引 3)
• Saponin from Tea (Camellia sinensis) Seed Meal Attenuates Cortisol-Induced Lipogenesis and Inflammation in Human Cells (2025 · Molecules · 被引 3)
• Design, synthesis, and biological profiling of fluorinated cannabidiol and cannabigerol derivatives as promising therapeutic agents (2026 · Journal of Cannabis Research · 被引 1)